Citizen Petition from Covington & Burling LLP on Behalf of Novo Nordisk Inc.
Details
The document's own metadata, straight from the source system.
- Title
- Citizen Petition from Covington & Burling LLP on Behalf of Novo Nordisk Inc.
- Posted
- Oct 23, 2024
Overview
What the public is saying — stance, who's commenting, and the issues they raise.
Stance breakdown
Who commented
Breakdown by commenter type.
Comments over time
Weekly arrivals, stacked by stance.
Support × commenter type
How each type splits across stance.
Issues raised
The docket's canonical issues. Select one to browse its comments.
Explorer
Every mirrored comment — filter by stance, campaign, or issue.
- May 13, 2026Comment from Holly AndersonSupportIndividual
Holly Anderson, a private individual, supports the petition by advocating for 503B compounding pharmacies to have access to GLP-1 drugs. She argues that these pharmacies provide essential, affordable access to medications like semeglutide and tirzepatide for patients who cannot afford the brand-name versions.
Read comment → - May 11, 2026Comment from Stephanie AlsupOpposeIndividual
An individual patient expresses strong opposition to the proposed action, arguing that it would restrict access to affordable compounded GLP-1 medications. They state that these medications are life-changing and necessary for patients who face significant cost barriers or lack insurance coverage.
Read comment →